Last reviewed · How we verify
Betamethasone dipropionate cream
Betamethasone dipropionate cream is a topical corticosteroid that reduces inflammation and itching by suppressing the immune system.
Betamethasone dipropionate cream is a topical corticosteroid that reduces inflammation and itching by suppressing the immune system. Used for Seborrheic dermatitis, Psoriasis.
At a glance
| Generic name | Betamethasone dipropionate cream |
|---|---|
| Also known as | Diprosone, Diprolene |
| Sponsor | LEO Pharma |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
It works by inhibiting the production of inflammatory mediators, such as prostaglandins and leukotrienes, which contribute to the symptoms of inflammation and itching. This results in a decrease in the number of immune cells, including eosinophils and lymphocytes, that contribute to the inflammatory response.
Approved indications
- Seborrheic dermatitis
- Psoriasis
Common side effects
- Skin atrophy
- Hypersensitivity reactions
Key clinical trials
- Assessing Psoriasis Treatment Outcomes (NA)
- A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects (PHASE3)
- Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant) (PHASE2, PHASE3)
- A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in Adults
- Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial (PHASE1, PHASE2)
- A Psoriasis Plaque Test With LEO 29102 Cream and Its Combination Products (PHASE2)
- A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) (PHASE1)
- Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Betamethasone dipropionate cream CI brief — competitive landscape report
- Betamethasone dipropionate cream updates RSS · CI watch RSS
- LEO Pharma portfolio CI